104 Results

Phase III clinical trial of GV 971 shows promise in Alzheimers disease.- Green Valley Pharma.

 Added 2 months ago

Green Valley Pharmaceutical Co announced promising findings from a Phase III clinical trial of GV 971, a multi targeting carbohydrate-based...

Global survey investigating perceptions of Alzheimer's disease-Novartis + Amgen + Banner.

 Added 4 months ago

Novartis, Amgen and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest global...

Successful Phase III A16 study of flortaucipir F 18 , a PET agent to predict Alzheimers disease diagnosis. - Eli Lilly.

 Added 4 months ago

Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, announced that a Phase III study...

Global phase III trials of lanabecestat in Alzheimers disease discontinued.- AstraZeneca + Eli Lilly.

 Added 7 months ago

AstraZeneca and Eli Lilly are discontinuing the global Phase III clinical trials of lanabecestat, for the treatment of Alzheimer’s disease....

Azeliragon fails Phase III STEADFAST trial in patients with mild Alzheimers disease.- vTv Therapeutics Inc.

 Added 9 months ago

vTv Therapeutics, Inc. has announced that results from Part A of the Company’s Phase III STEADFAST study of the investigational...

Brain Awareness Week (BAW) 2018

 Added 10 months ago

Brain Awareness Week (BAW) 2018

A tipple a day keeps the doctor away

 Added 11 months ago

A tipple a day keeps the doctor away

New research from the journal Scientific Reports suggests that low level alcohol consumption can actually be good for the brain.

Load more